Denzel Eggermont
Impact in
-
- Moyamoya disease diagnosis and treatment
-
- interferon and immune responses
- Immunotherapy and Immune Responses
Papers in
-
- vaccines and immunoinformatics approaches 2
-
- interferon and immune responses 2
- Immunotherapy and Immune Responses 1
- Co-authors
- Francis Impens (5 shared papers)Fabien Théry (4 shared papers)Dimitri Hemelsoet (1 shared paper)Bart Dermaut (1 shared paper)Antje Beling (1 shared paper)Andreas Damianou (1 shared paper)Qi Wen Teo (1 shared paper)Horace H.Y. Lee (1 shared paper)
- Journals
- Frontiers in Immunology (1 paper)Nature Immunology (1 paper)Molecular & Cellular Proteomics (1 paper)Trends in Molecular Medicine (1 paper)Nature Communications (1 paper)
- Partner nations
- BelgiumUnited StatesHong Kong
In The Last Decade
Denzel Eggermont
5 papers receiving 246 citations
Peers
Comparison fields: 5 of 58
- Rheumatology 63
- Immunology 80
- Infectious Diseases 63
- Neurology 26
- Molecular Medicine 7
Countries citing papers authored by Denzel Eggermont
This map shows the geographic impact of Denzel Eggermont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denzel Eggermont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denzel Eggermont more than expected).
Fields of papers citing papers by Denzel Eggermont
This network shows the impact of papers produced by Denzel Eggermont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denzel Eggermont. The network helps show where Denzel Eggermont may publish in the future.
Co-authors
The 25 scholars most cited alongside Denzel Eggermont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 91 | |
| 2 | 2022 | 64 | |
| 3 | 2022 | 64 | |
| 4 | 2021 | 22 | |
| 5 | 2024 | 7 |
About Denzel Eggermont
Denzel Eggermont is a scholar working on Molecular Biology, Immunology, Biomedical Engineering, Infectious Diseases and Cardiology and Cardiovascular Medicine, having authored 5 papers that have together received 248 indexed citations. Recurring topics across this work include Biosensors and Analytical Detection (2 papers), vaccines and immunoinformatics approaches (2 papers), interferon and immune responses (2 papers), COVID-19 Clinical Research Studies (1 paper), Neurological Complications and Syndromes (1 paper), Immunotherapy and Immune Responses (1 paper), Moyamoya disease diagnosis and treatment (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Rheumatology (63 citations), Immunology (80 citations), Infectious Diseases (63 citations), Neurology (26 citations) and Molecular Medicine (7 citations). Denzel Eggermont has collaborated with scholars based in Belgium, United States and Hong Kong. Frequent co-authors include Francis Impens, Fabien Théry, Dimitri Hemelsoet, Bart Dermaut, Antje Beling, Andreas Damianou, Qi Wen Teo, Horace H.Y. Lee, Lewis Siu and Wilson W. Ng. Their work appears in journals such as Frontiers in Immunology, Nature Immunology, Molecular & Cellular Proteomics, Trends in Molecular Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.